KURA
Kura Oncology Inc
NASDAQ · Biotechnology
$7.83
+0.43 (+5.81%)
Open$7.54
Previous Close$7.40
Day High$7.88
Day Low$7.54
52W High$12.49
52W Low$5.41
Volume—
Avg Volume1.27M
Market Cap681.35M
P/E Ratio—
EPS$-2.48
SectorBiotechnology
Analyst Ratings
Strong Buy
21 analysts
Price Target
+486.5% upside
Current
$7.83
$7.83
Target
$45.92
$45.92
$25.11
$45.92 avg
$52.51
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 54.42M | 146.41M | 142.51M |
| Net Income | -175,714,475 | 21.31M | 25.50M |
| Profit Margin | -322.9% | 14.6% | 17.9% |
| EBITDA | -194,162,189 | 41.90M | 41.44M |
| Free Cash Flow | — | 24.20M | 22.28M |
| Rev Growth | — | -6.0% | +22.0% |
| Debt/Equity | 0.02 | 0.38 | 0.34 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |